HWG Holdings’s Biogen BIIB Stock Holding History

HWG Holdings’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-145	Closed	-$37.4K	–	107
2020 Q3	$41K	Hold	145	–	–	0.04%	78
2020 Q2	$39K	Buy	+145	New	+$43.6K	0.03%	82
2019 Q4	$47K	Buy	+159	New	+$44.1K	0.04%	84

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

HWG Holdings's BIIB Position: Q4 2020 in Review

HWG Holdings sold out of Biogen (BIIB) in Q4 2020, closing a stake of 145 shares — an estimated $37.4K sold.

HWG Holdings first reported a position in BIIB in Q4 2019 and held it in 3 quarters. The position peaked at $47K in Q4 2019. 1,062 funds tracked by Wall St. Rank hold BIIB as of Q4 2020.

HWG Holdings reported no remaining Biogen position as of Q4 2020 after selling out during the quarter.
HWG Holdings sold 145 Biogen shares in Q4 2020, an estimated $37.4K.
HWG Holdings first reported a position in Biogen in Q4 2019 and held it in 3 quarters.
HWG Holdings's Biogen position peaked at $47K in Q4 2019.
1,062 funds tracked by Wall St. Rank held Biogen as of Q4 2020.

Based on HWG Holdings's 13F filing for Q4 2020, filed 20 Jan 2021.